Cohort A (N=244) | |||
COVID-19 children (n=30) | Other patients (n=214) | P value | |
Age groups | |||
< 1 year, n (%) | 6 (20%) | 53 (24.8%) | 0.6549 |
1–5 years, n (%) | 12 (40%) | 66 (30.8%) | 0.403 |
6–10 years, n (%) | 8 (26.6%) | 47 (22%) | 0.6407 |
11–17 years, n (%) | 4 (13.3%) | 48 (22.4%) | 0.343 |
Symptoms | |||
Fever (body temperature >37.5°C), n | 28 | 168 | 0.083 |
Dry cough, n | 16 | 68 | 0.025 |
Diarrhoea, n | 3 | 28 | 0.777 |
Dyspnoea/tachypnoea, n | 3 | 27 | 1.000 |
Sore throat, n | 1 | 11 | 1.000 |
Smell and taste dysfunction, n | 0 | 0 | NA |
Chest pain, n | 0 | 6 | 1.000 |
Vomiting, n | 0 | 16 | 0.231 |
At least one symptom*, n | 30 | 210 | 1 |
At least two symptoms*, n | 19 | 100 | 0.11 |
At least three symptoms*, n | 2 | 12 | 0.68 |
Fever with at least another symptom†, n | 18 | 86 | 0.0489 |
Fever with at least one upper airway symptom‡, n | 16 | 65 | 0.021 |
Close contact with a COVID-19 relative, n | 18 | 14 | <0.01 |
*Including dry cough, diarrhoea, dyspnoea, tachypnoea, sore throat, smell and taste dysfunction, chest pain or vomiting.
†Including fever, dry cough, diarrhoea, dyspnoea, tachypnoea, sore throat, smell and taste dysfunction, chest pain or vomiting.
‡Including dyspnoea, dry cough, sore throat or smell and taste dysfunction.